Hematology TimesIV bevacizumab improves severe bleeding in HHTJanuary 31, 2018ThrombosisBleeding Disorders
Hematology NewsGene therapy moves from promise to realityJanuary 25, 2018Bleeding DisordersMultiple MyelomaImmunotherapy
Hematology NewsSotatercept promising for treatment of anemia in MDSJanuary 24, 2018AnemiaMyelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationBleeding Disorders
Hematology TimesLow inhibitor rate observed in PUPs with hemophilia AJanuary 24, 2018ThrombosisBleeding Disorders
Hematology TimesEC approves product to treat hemophilia AJanuary 17, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesEmicizumab still available despite legal issuesJanuary 14, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesCaplacizumab improves outcomes in aTTPJanuary 5, 2018AnemiaThrombosisBleeding Disorders
Hematology NewsFDA grants breakthrough therapy designation for severe aplastic anemia drugJanuary 4, 2018AnemiaRare DiseasesPediatricsBleeding Disorders
Hematology NewsStudy identifies predictors of acquired von Willebrand diseaseDecember 26, 2017Indolent LymphomaLymphoma & Plasma Cell DisordersBleeding Disorders
Hematology TimesFDA lifts clinical hold on fitusiran trialsDecember 19, 2017ThrombosisBleeding Disorders
Hematology NewsVIDEO: Caplacizumab sped platelet response, improved clinical outcomes in acquired TTPDecember 12, 2017Bleeding Disorders
